vs

Side-by-side financial comparison of PTC THERAPEUTICS, INC. (PTCT) and UNITIL CORP (UTL). Click either name above to swap in a different company.

PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $161.5M, roughly 1.0× UNITIL CORP). UNITIL CORP runs the higher net margin — 11.8% vs -82.0%, a 93.7% gap on every dollar of revenue. On growth, UNITIL CORP posted the faster year-over-year revenue change (26.7% vs -22.7%). UNITIL CORP produced more free cash flow last quarter ($-36.3M vs $-36.6M). Over the past eight quarters, UNITIL CORP's revenue compounded faster (-4.9% CAGR vs -11.5%).

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.

Unitil Corporation is an interstate electricity and natural gas utility company that provides services for New Hampshire, Massachusetts and Maine. Its earliest predecessor company, the Portland Gas Light Company, was founded in Maine in 1849. The current company was set up in 1984 and is based in New Hampshire. With a market cap of 686.51M, it provides electric services to about 102,400 customers and natural gas to over 75,900 customers. The service territory of Unitil includes business distr...

PTCT vs UTL — Head-to-Head

Bigger by revenue
PTCT
PTCT
1.0× larger
PTCT
$164.7M
$161.5M
UTL
Growing faster (revenue YoY)
UTL
UTL
+49.4% gap
UTL
26.7%
-22.7%
PTCT
Higher net margin
UTL
UTL
93.7% more per $
UTL
11.8%
-82.0%
PTCT
More free cash flow
UTL
UTL
$347.0K more FCF
UTL
$-36.3M
$-36.6M
PTCT
Faster 2-yr revenue CAGR
UTL
UTL
Annualised
UTL
-4.9%
-11.5%
PTCT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PTCT
PTCT
UTL
UTL
Revenue
$164.7M
$161.5M
Net Profit
$-135.0M
$19.0M
Gross Margin
Operating Margin
-43.3%
21.5%
Net Margin
-82.0%
11.8%
Revenue YoY
-22.7%
26.7%
Net Profit YoY
-104.8%
21.8%
EPS (diluted)
$-1.63
$1.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PTCT
PTCT
UTL
UTL
Q4 25
$164.7M
$161.5M
Q3 25
$211.0M
$101.1M
Q2 25
$178.9M
$102.6M
Q1 25
$1.2B
$170.8M
Q4 24
$213.2M
$127.5M
Q3 24
$196.8M
$92.9M
Q2 24
$186.7M
$95.7M
Q1 24
$210.1M
$178.7M
Net Profit
PTCT
PTCT
UTL
UTL
Q4 25
$-135.0M
$19.0M
Q3 25
$15.9M
$-300.0K
Q2 25
$-64.8M
$4.0M
Q1 25
$866.6M
$27.5M
Q4 24
$-65.9M
$15.6M
Q3 24
$-106.7M
$0
Q2 24
$-99.2M
$4.3M
Q1 24
$-91.6M
$27.2M
Operating Margin
PTCT
PTCT
UTL
UTL
Q4 25
-43.3%
21.5%
Q3 25
1.4%
6.9%
Q2 25
-19.5%
13.0%
Q1 25
82.5%
27.0%
Q4 24
-76.2%
22.1%
Q3 24
-27.7%
6.2%
Q2 24
-21.5%
13.0%
Q1 24
-21.6%
24.7%
Net Margin
PTCT
PTCT
UTL
UTL
Q4 25
-82.0%
11.8%
Q3 25
7.5%
-0.3%
Q2 25
-36.3%
3.9%
Q1 25
73.7%
16.1%
Q4 24
-30.9%
12.2%
Q3 24
-54.2%
Q2 24
-53.1%
4.5%
Q1 24
-43.6%
15.2%
EPS (diluted)
PTCT
PTCT
UTL
UTL
Q4 25
$-1.63
$1.05
Q3 25
$0.20
$-0.02
Q2 25
$-0.83
$0.25
Q1 25
$10.04
$1.69
Q4 24
$-0.85
$0.97
Q3 24
$-1.39
$0.00
Q2 24
$-1.29
$0.27
Q1 24
$-1.20
$1.69

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PTCT
PTCT
UTL
UTL
Cash + ST InvestmentsLiquidity on hand
$1.9B
$15.6M
Total DebtLower is stronger
$670.5M
Stockholders' EquityBook value
$-205.3M
$609.6M
Total Assets
$2.9B
$2.1B
Debt / EquityLower = less leverage
1.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PTCT
PTCT
UTL
UTL
Q4 25
$1.9B
$15.6M
Q3 25
$1.7B
$14.6M
Q2 25
$2.0B
$8.5M
Q1 25
$2.0B
$10.2M
Q4 24
$1.1B
$6.3M
Q3 24
$1.0B
$6.3M
Q2 24
$1.1B
$2.8M
Q1 24
$884.8M
$6.3M
Total Debt
PTCT
PTCT
UTL
UTL
Q4 25
$670.5M
Q3 25
$670.5M
Q2 25
$640.7M
Q1 25
$642.1M
Q4 24
$643.3M
Q3 24
$643.3M
Q2 24
$511.3M
Q1 24
$512.8M
Stockholders' Equity
PTCT
PTCT
UTL
UTL
Q4 25
$-205.3M
$609.6M
Q3 25
$-155.8M
$597.2M
Q2 25
$-206.5M
$532.8M
Q1 25
$-185.8M
$534.1M
Q4 24
$-1.1B
$512.5M
Q3 24
$-1.1B
$502.4M
Q2 24
$-980.2M
$508.8M
Q1 24
$-893.9M
$510.8M
Total Assets
PTCT
PTCT
UTL
UTL
Q4 25
$2.9B
$2.1B
Q3 25
$2.6B
$1.9B
Q2 25
$2.6B
$1.9B
Q1 25
$2.7B
$1.9B
Q4 24
$1.7B
$1.8B
Q3 24
$1.8B
$1.7B
Q2 24
$1.9B
$1.7B
Q1 24
$1.8B
$1.7B
Debt / Equity
PTCT
PTCT
UTL
UTL
Q4 25
1.10×
Q3 25
1.12×
Q2 25
1.20×
Q1 25
1.20×
Q4 24
1.26×
Q3 24
1.28×
Q2 24
1.00×
Q1 24
1.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PTCT
PTCT
UTL
UTL
Operating Cash FlowLast quarter
$-34.3M
$21.4M
Free Cash FlowOCF − Capex
$-36.6M
$-36.3M
FCF MarginFCF / Revenue
-22.3%
-22.5%
Capex IntensityCapex / Revenue
1.4%
35.7%
Cash ConversionOCF / Net Profit
1.13×
TTM Free Cash FlowTrailing 4 quarters
$702.3M
$-53.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PTCT
PTCT
UTL
UTL
Q4 25
$-34.3M
$21.4M
Q3 25
$-66.3M
$15.6M
Q2 25
$-58.3M
$42.2M
Q1 25
$870.1M
$52.1M
Q4 24
$-30.0M
$23.3M
Q3 24
$-77.0M
$26.1M
Q2 24
$-71.5M
$49.9M
Q1 24
$70.8M
$26.6M
Free Cash Flow
PTCT
PTCT
UTL
UTL
Q4 25
$-36.6M
$-36.3M
Q3 25
$-69.7M
$-39.0M
Q2 25
$-59.6M
$2.0M
Q1 25
$868.4M
$19.5M
Q4 24
$-33.8M
$-32.3M
Q3 24
$-77.5M
$-31.3M
Q2 24
$-78.8M
$13.2M
Q1 24
$61.2M
$6.4M
FCF Margin
PTCT
PTCT
UTL
UTL
Q4 25
-22.3%
-22.5%
Q3 25
-33.1%
-38.6%
Q2 25
-33.3%
1.9%
Q1 25
73.8%
11.4%
Q4 24
-15.8%
-25.3%
Q3 24
-39.4%
-33.7%
Q2 24
-42.2%
13.8%
Q1 24
29.1%
3.6%
Capex Intensity
PTCT
PTCT
UTL
UTL
Q4 25
1.4%
35.7%
Q3 25
1.6%
54.0%
Q2 25
0.7%
39.2%
Q1 25
0.1%
19.1%
Q4 24
1.8%
43.6%
Q3 24
0.3%
61.8%
Q2 24
4.0%
38.3%
Q1 24
4.6%
11.3%
Cash Conversion
PTCT
PTCT
UTL
UTL
Q4 25
1.13×
Q3 25
-4.17×
Q2 25
10.55×
Q1 25
1.00×
1.89×
Q4 24
1.49×
Q3 24
Q2 24
11.60×
Q1 24
0.98×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons